Security key
53220K504
LIGAND PHARMACEUTICALS INC - Common Stock (LGND)
CUSIP: 53220K504
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 22,595,515
- Total 13F value
- $7,136,843,751
- Share change
- +1,728,595
- Put/Call ratio
- 92%
- SEC-reported price per share
- $316.09
- Number of holders
- 412
- Value change
- +$564,158,556
- Number of buys
- 241
- Number of sells
- 147
- Shares outstanding
- 19,981,082
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
412
Top holders
10
LGND full security history
Ownership snapshot
Full 13F holder table
LIGAND PHARMACEUTICALS INC SEC filings
LIGAND PHARMACEUTICALS INC company facts
LIGAND PHARMACEUTICALS INC 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of LGND - LIGAND PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 14%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
14%
Invesco Ltd.
6.1%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.6%
Janus Henderson Group Ltd.
5.3%
VANGUARD CAPITAL MANAGEMENT LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
14%
from 13D/G
|
$591,347,927
2,961,923 shares
|
— | 31 Mar 2026 |
| Invesco Ltd. |
13D/G
13F
Company
|
6.1%
|
$385,447,859
1,218,846 shares
|
$0 | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
5.6%
|
$236,737,830
1,109,154 shares
|
$0 | 31 Mar 2026 |
| Janus Henderson Group Ltd. |
13F
13D/G
Company · JANUS HENDERSON GROUP PLC
|
5.3%
from 13D/G
|
$201,622,937
1,009,891 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5%
|
$212,935,641
997,637 shares
|
$0 | 31 Mar 2026 |
| Stephen L. Sabba |
3/4/5
Director
|
0.17%
|
$8,541,766
33,629 shares
|
-$1,162,554 | 16 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
412
Shares
22,595,515
Rows available
412
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
358
Q2 2026 holders
412
Holder diff
54
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|